
Report ID: SQMIG35A3042
Skyquest Technology's expert advisors have carried out comprehensive research on the cardiac prosthetic devices market to identify the major global and regional market trends and growth opportunities for leading players and new entrants in this market. The analysis is based on in-depth primary and secondary research to understand the major market drivers and restraints shaping the future development and growth of the industry.
Rising Cardiovascular Diseases
Technological Advancements in Medical Devices
Complicated Regulatory Approvals
Risk of Complications and Side Effects
REQUEST FOR SAMPLE
Global Cardiac Prosthetic Devices Market size was valued at USD 74.03 Billion in 2023 poised to grow from USD 77.53 Billion in 2024 to USD 112.21 Billion by 2032, growing at a CAGR of 4.73% in the forecast period (2025-2032).
The global cardiac prosthetic devices market competitive scenario is dominated by Edwards Lifesciences, Medtronic, Abbott Laboratories, and Boston Scientific. These firms operate with innovation, mergers and acquisitions to keep the leadership intact. Edwards Lifesciences leads with research efforts in heart valve technologies, Medtronic continues to expand minimally invasive surgery solutions, and Abbott supplements its product portfolio with strategic acquisitions for a wide offering of advanced cardiac solutions. 'Edwards Lifesciences (USA)', 'Medtronic (Ireland)', 'Abbott Laboratories (USA)', 'Boston Scientific (USA)', 'CryoLife (USA)', 'Terumo Corporation (Japan)', 'Johnson & Johnson (USA)', 'Sorin Group (Italy)', 'LivaNova (UK)', 'Cardinal Health (USA)', 'Biotronik (Germany)', 'Tendyne (USA)', 'Aortic Medical (USA)', 'Mitsubishi Tanabe Pharma Corporation (Japan)', 'Vascular Solutions (USA)'
The rising incidences of cardiac diseases globally represent one of the biggest drivers in the global cardiac prosthetic devices market growth. As cardiac issues such as heart valve disease and coronary artery diseases rise, more prosthetic devices like heart valves and vascular grafts are required, which translates into greater opportunities for innovation and growth in the market.
Advancements in Minimally Invasive Procedures: The global cardiac prosthetic devices market trends are directing toward minimally invasive procedures, which reduce recovery times and risks. These kinds of devices, for example, transcatheter heart valves and catheter-based repair systems, are getting popular due to smaller incisions and faster recovery time.
What Factors Contribute to North America's Leadership in the Global Cardiac Prosthetic Devices Market?
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35A3042
[email protected]
USA +1 351-333-4748